Keyphrases
Transcatheter Aortic Valve Replacement
95%
Surgical Aortic Valve Replacement
89%
Transcatheter Valve
72%
Transcatheter
57%
Severe Aortic Stenosis
46%
Clinical High Risk
37%
Intermediate Risk
23%
Acute Rejection
23%
Allograft
22%
HLA-A2
22%
Airway Epithelial Cells
22%
Transgenic
22%
2-year Outcome
22%
Cardiac Allograft
22%
Bronchiolitis Obliterans Syndrome
22%
Aortic Stenosis
18%
Aortic Valve Replacement
17%
Health Status
17%
Anti-HLA
16%
Mitral Regurgitation
15%
HLA Class I
13%
Tumor Necrosis Factor-α
13%
Confidence Interval
12%
Lung Transplantation
12%
Major Vascular Injury
12%
High Risk
12%
Medicare Reimbursement
11%
Lung Allograft Rejection
11%
PARTNER Trial
11%
Cardiovascular Devices
11%
Epithelial Cell Damage
11%
Antigen-specific T Cells
11%
Living Donor Kidney Transplantation
11%
Obliterative Airway Disease
11%
Cadaver Organ Transplantation
11%
Kidney Allograft Biopsy
11%
Neutrophil-to-lymphocyte Ratio
11%
Cadaveric
11%
Tolerance Induction
11%
Femoral Access
11%
Antigen Presentation Pathway
11%
Allograft Model
11%
CD4+ T
11%
Organ Donation
11%
Clinical Staging
11%
Antibody Binding
11%
Cell Recognition
11%
Ethical Considerations
11%
Possible Mechanisms
11%
5-year Outcomes
11%
Medicine and Dentistry
Aortic Valve Replacement
100%
Percutaneous Aortic Valve Replacement
84%
Aortic Stenosis
56%
Allograft
33%
Quality of Life
24%
Mitral Insufficiency
22%
Apoplexy
21%
Health Status
18%
T Cell
14%
In Vitro
13%
Hazard Ratio
13%
Tumor Necrosis Factor
13%
Acute Graft Rejection
12%
Health Care Cost
12%
Cardiovascular System
12%
Cell Damage
11%
Respiratory Disease
11%
Epithelial Cell
11%
Neutrophil
11%
Neutralization
11%
Lung Graft Rejection
11%
Antigen Specificity
11%
Lymphocyte Antibody
11%
Medicare
11%
Kidney Transplantation
11%
Cyclosporine
11%
Bronchiolitis Obliterans
11%
T Cell Proliferation
11%
Cost-Effectiveness Analysis
11%
Organ Transplantation
11%
Kidney Allograft
11%
Patient with Diabetes
11%
Lung
11%
Lymphocyte
11%
Biopsy Technique
11%
Living Donors
11%
Myocardial Disease
10%
All Cause Mortality
8%
Transplantation
8%
Transcatheter Aortic Valve Replacement
8%
Alloantigen
6%
Diabetes
6%
Interferon
6%
Survival Rate
5%
Cytokine
5%
Interleukin 2
5%
Endovascular Surgery
5%
Vascular Access
5%
Femoral Artery
5%
Surgery
5%
Immunology and Microbiology
Allograft
55%
Acute Graft Rejection
23%
Transgenics
22%
Bronchiolitis
22%
T Cell
15%
Tumor Necrosis Factor
13%
T-Helper Cell
12%
C57BL 6 Mouse
12%
Immunology
12%
Lung Graft Rejection
11%
Neutrophil
11%
Neutralization
11%
Binding Antibody
11%
Growth Factor
11%
Apoptosis
11%
Antigen Specificity
11%
Aortic Valve
11%
Fibrogenesis
11%
Cell Damage
11%
Antigen Presentation
11%
T Cell Proliferation
11%
Ciclosporin
11%
Anti-Lymphocyte Globulin
11%
Lymphocyte
11%
Monoclonal Antibody
8%
Splenocyte
7%
interferon
7%
CD8
7%
Buffalo
6%
Alloantigen
6%
Lung Transplantation
6%
Cytokine
6%
Interleukin 2
5%
CD4
5%
Inflammatory Cytokine
5%
Survival Time
5%
Interleukin 1
5%
Fibroblast
5%
